Announcements
Sidley Represents D1 Capital in Imperative Care US$150 Million Series E Financing
August 7, 2024
Sidley represented D1 Capital Partners as an investor in the US$150 million Series E financing round of Imperative Care, a commercial-stage medical technology company researching and developing connected innovations to elevate care for people affected by vascular diseases such as stroke and pulmonary embolism. Also participating in the round were other existing investors including Ally Bridge Group, AMED Ventures, Bain Capital Life Sciences, Innovatus Capital Partners, LLC, Pura Vida Investments, and Rock Springs Capital Management LP.
The Sidley team was led by Geoffrey W. Levin (M&A and Private Equity) and included Chris Crane (M&A and Private Equity), Jamie M. Sadler (Antitrust and Competition), Katie Klaben (Capital Markets), and Ching-Lee Fukuda and Sharon Lee (IP Litigation).
The Sidley team was led by Geoffrey W. Levin (M&A and Private Equity) and included Chris Crane (M&A and Private Equity), Jamie M. Sadler (Antitrust and Competition), Katie Klaben (Capital Markets), and Ching-Lee Fukuda and Sharon Lee (IP Litigation).
Contacts
Capabilities
Suggested News & Insights
Delaware Court of Chancery Draws a Line on Release Conditions in M&AJuly 8, 2026EU Forced Labor Regulation Moves Toward Implementation: How Companies Should PrepareJuly 7, 2026Sidley Represents Clara Vista Investment Partners in Its Acquisition of Majority Stake in Frosinone CalcioJuly 6, 2026Sidley Represents Olympus Power in Formation of Winslow Power Joint Venture and Acquisition of Generating AssetsJuly 6, 2026Sidley Adds Insurance M&A Partner Carl Hotton To Growing London OfficeJuly 2, 2026A Purchase-Price Adjustment Is Not the End of the Road With Indemnification on the TableJuly 1, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory